InvestorBrandNetwork (IBN) Content Platform

Starco Brands (OTCQB: STCB), an inventor and acquirer of consumer products with behavior-changing technologies that spark excitement in the everyday, and Skylar, a business unit under the brand, announced that Skylar’s newest product achieved unprecedented success as the company’s most successful launch with Sephora; Sephora is the industry’s leading beauty retailer. According to the announcement, Skylar released its third new scent of the year — Boardwalk Delight — which sold out at Sephora and on skylar.com within 10 days. A creator of clean fragrances designed to help individuals feel beautiful, confident and safe in their skin, Skylar noted that Boardwalk Delight, its latest eau de parfum, is the company’s 10th scent offered by Sephora at more than 500 retail locations. According to the announcement, Boardwalk Delight features a blend of cotton candy, raspberry sorbet and creamy coconut milk balanced by the warmth of pure vanilla. “Boardwalk Delight sold out at Sephora and on skylar.com within 10 days of launching, proving that more and more consumers are seeking artfully crafted fragrances with safe ingredients,” said Skylar vice president of marketing Sara Miranda in the press release. “We are proud to partner with Sephora to educate consumers on the importance of clean fragrance.”

To view the full press release, visit https://ibn.fm/NaEV8

About Starco Brands, Inc.

Starco Brands invents consumer products with behavior-changing technologies that spark excitement in the everyday. Today, its disruptive brands include Whipshots(R), the world’s only vodka-infused whipped cream; Art of Sport, the body-care brand designed for athletes and cofounded by Kobe Bryant; Winona(R) Popcorn Spray, the first indulgent theater-popcorn spray powered by air; Skylar, the only fragrance that is both hypoallergenic and safe for sensitive skin; and Soylent, the complete nondairy nutrition brand. A modern-day invention factory to its core, Starco Brands identifies whitespaces across consumer product categories. It draws upon a portfolio of innovative formulas spanning eight product categories with limitless innovation potential. For more information about the company, please visit www.StarcoBrands.com.

NOTE TO INVESTORS: The latest news and updates relating to STCB are available in the company’s newsroom at http://ibn.fm/STCB

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork

Movella Holdings (NASDAQ: MVLA), a full-stack hardware, software and data analytics company, has appointed Steven Smith as the company chief financial officer. Smith brings more than two decades of experience to the position, which calls for him to oversee Movella’s financial strategy and investor relations. The company is focused on digitizing movement, enabling people to extract meaning and impact positive change by providing intelligent solutions for sensing, capturing and analyzing motion and states of being. According to the announcement, Movella’s proprietary line of products are designed to accelerate innovation in entertainment, sports, health and industrial markets. Before joining Movella, Smith served in several key leadership positions, including as executive vice president and chief financial officer for Inseego Corp. (NASDAQ: INSG) as part of the company’s turnaround team; in those positions, he played a key role as Inseego’s market cap increased from $50 million to $1.5 billion. Prior to Inseego, he served as interim CFO of TetraVue Inc., a developer of high definition 4D LIDAR technology, and as CFO and head of operations for Micropower Technologies, a private equity-backed business. “I am pleased to welcome Steve to our executive team,” said Movella CEO Ben Lee in the press release. “His deep financial and business experience in SaaS and health technology will be instrumental as we continue to transform Movella. Steve’s track record of success as a public company CFO will prepare Movella for our next phase of growth.”

To view the full press release, visit https://ibn.fm/ORs4R

About Movella Holdings Inc.

Movella is a full-stack hardware, software and data analytics company created by the consolidation of mCube, Xsens and Kinduct. Movella is a global innovator of advanced technologies and products that sense, capture and analyze all aspects of movement. Movella serves the entertainment, sports, health and industrial markets by capturing and transforming movement data into meaningful and actionable insights. Working with leading global brands such as Electronic Arts, NBC Universal, Netflix, Daimler, Siemens and more than 500 sports teams, Movella is creating extraordinary outcomes that move humanity forward. For more information about the company, please visit www.Movella.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork

Fresh2 Group (NASDAQ: FRES), formerly AnPac Bio-Medical Science Co., is a company with operations in the United States and China focused on early cancer screening and detection with plans to enter into the operation of a business-to-business e-commerce food platform focused on the sale of Asian-sourced food products. The company today announced that on June 2, 2023, it completed a private placement of 22,000,000 Class A ordinary shares and warrants to purchase 22,000,000 Class A ordinary shares for $4.4 million. Fresh2 Group intends to use the proceeds for general corporate purposes, including working capital. The company’s American Depositary Shares (“ADSs”) are listed on the NASDAQ Capital Market, with each ADS representing 20 Class A ordinary shares. The purchase price was $0.20 per share ($4.00 per ADS). The warrants have an exercise price of $4.20 per ADS and are exercisable within two years of the date of issuance. There is no established trading market for the warrants.

To view the full press release, visit https://ibn.fm/U3GF9

About Fresh2 Group Limited

Fresh2 Group is a biotechnology company focused on early cancer screening and detection, with 155 issued patents as of March 31, 2023. With two certified clinical laboratories in China and one CLIA and CAP accredited clinical laboratory in the United States, Fresh2 performs a suite of cancer screening and detection tests, including CDA (Cancer Differentiation Analysis), bio-chemical, immunological and genomics tests. The company is entering the business-to-business e-commerce food business with the formation of its wholly-owned subsidiary Fresh2 Technology Inc. and the acquisition of Fresh2 Ecommerce Inc. For more information, visit https://fresh2.co/investors.

NOTE TO INVESTORS: The latest news and updates relating to FRES are available in the company’s newsroom at https://ibn.fm/FRES

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork

Tingo Group (NASDAQ: TIO), a global fintech and agri-fintech group of companies with operations in Africa, southeast Asia and the Middle East, has scheduled a Special Meeting of Stockholders; the meeting will include a Q&A segment. The meeting is slated to begin at 9 a.m. ET on June 7, 2023. According to the announcement, the meeting will be held virtually via a webcast, and stockholders are encouraged to submit questions prior to the meeting via email. The company noted that Tingo Group holders of record of common stock at close of business on April 24, 2023, are entitled to vote at the meeting; votes can by cast virtually or by proxy.

To view the full press release, visit https://ibn.fm/twsZg

About Tingo Group Inc.

Tingo Group is a global fintech and agri-fintech group of companies with operations in Africa, southeast Asia and the Middle East. Tingo Group’s wholly owned subsidiary, Tingo Mobile, is the leading agri-fintech company operating in Africa, with a comprehensive portfolio of innovative products, including a device-as-a-service smartphone and preloaded platform product. As part of its globalization strategy, Tingo Mobile has recently begun to expand internationally and entered into trade partnerships that are contracted to increase the number of subscribed farmers from 9.3 million in 2022 to more than 32 million, providing the farmers with access to services such as the Nwassa seed-to-sale marketplace platform, insurance, microfinance, and mobile phone and data top-up. Tingo Group’s other Tingo business verticals include TingoPay, a SuperApp in partnership with Visa that offers a wide range of B2C and B2B services including payment services, an e-wallet, foreign exchange and merchant services; Tingo Foods, a food-processing business that processes raw foods into finished products such as rice, pasta and noodles; and Tingo DMCC, a commodity trading platform and agricultural commodities export business based out of the Dubai Multi Commodities Center. In addition to its Tingo business verticals, Tingo Group also holds and operates an insurance brokerage platform business in China, with more than 130 offices located in China’s cities and major towns; and Magpie Securities, a regulated finance services fintech business operating out of Hong Kong and Singapore. For more information, visit the company’s website at www.TingoGroup.com.

NOTE TO INVESTORS: The latest news and updates relating to TIO are available in the company’s newsroom at https://ibn.fm/TIO

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork

Clinical research, contract specialists, clinical operations, regulatory affairs, and legal strategists will all convene at Dynamic Global Events’ (“DGE’s”) 4th Clinical Trial Agreements Forum, returning to in-person learning on August 29-30 in Philadelphia, PA. As the only industry forum to specifically focus on Clinical Trial Agreements (‘‘CTAs’’), this will be a must-attend for legal, regulatory, and clinical contracting professionals who want to stay ahead of the curve on the latest strategies to overcome the industry’s most pressing challenges.

The two-day conference is designed to provide a unique networking and learning experience on the key insights and the latest trends, best practices, and most critical factors impacting the effectiveness and efficiency of your Clinical Trial Agreements. Attendees will enrich their knowledge of how best to…

Read More>>

For more information about this event, please visit https://ibn.fm/6ZQEr.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
Editor@InvestorWire.com

Cybin (NEO: CYBN) (NYSE American: CYBN), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment options, is making changes in its scientific management team. The company announced that Michael Palfreyman, PhD, and Brett Greene, both of whom joined Cybin as part of the acquisition of Adelia Therapeutics, will be moving into advisory roles; the company noted that Alex Nivorozhkin, PhD, will continue as Cybin’s chief scientific officer. The changes come as final milestones identified by the contribution agreement between Cybin and Adelia Therapeutics have been reached. Since the acquisition, Palfreyman has been serving as Cybin’s chief R&D officer and Greene had been serving as chief innovations officer. “We are extremely grateful for the opportunity to work with Mike and Brett, whose deep knowledge of psychedelics and drug development has helped Cybin to advance its programs quickly and efficiently to the clinic,” said Cybin CEO Doug Drysdale in the press release. “The Adelia acquisition was highly successful, providing us with many of the tools needed to accelerate our programs through the clinic and progressing our novel psychedelic-based therapeutics for patients in need. Cybin and Adelia established ambitious goals at the time of the acquisition, and Mike and Brett were integral to achieving them. We look forward to their continued contributions in their new roles as advisors to Cybin.”

To view the full press release, visit https://ibn.fm/FChk7

About Cybin Inc.

Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. Cybin’s goal of revolutionizing mental healthcare is supported by a network of world-class partners and internationally recognized scientists aimed at progressing proprietary drug-discovery platforms, innovative drug-delivery systems, and novel formulation approaches and treatment regimens. The company is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder, and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder; the company also has a research pipeline of investigational psychedelic-based compounds. For more information, visit the company’s website at www.Cybin.com.

NOTE TO INVESTORS: The latest news and updates relating to CYBN are available in the company’s newsroom at https://ibn.fm/CYBN

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork

Playgon Games (TSX.V: DEAL) (OTC: PLGNF) (FSE: 7CR), a SaaS technology company delivering innovative mobile live dealer technology to online gaming operators globally, today announced the attainment of key milestones in the current quarter. According to the announcement, Playgon achieved a record-breaking month in wagering its live dealer platform, surpassing $160,000,000, which betters its previous best month in March 2023 by 10%. The company’s daily wagering average continues to show increased growth with another new monthly record for Playgon of $5,156,000, a 12% increase over its previous best daily wagering average for a month in March. “Our integration pipeline is strong, we continue to on-board customers and our business is scaling,” said Darcy Krogh, CEO of Playgon Games. “We look forward to continued traction for our innovative mobile centric live dealer offering.”

To view the full press release, visit https://ibn.fm/Ql1p2

About Playgon Games Inc.

Playgon is a SaaS technology company focused on developing and licensing digital content for the growing iGaming market. The company provides a multitenant gateway that allows online operators the ability to offer their customers innovative iGaming software solutions. Its current software platform includes Live Dealer Casino, E-Table games and Daily Fantasy Sports, which, through a seamless integration at the operator level, allows customer access without having to share or compromise any sensitive customer data. As a true business-to-business digital content provider, the company’s products are ideal turnkey solutions for online casinos, sportsbook and land-based operators, media groups, and big database companies. For further information, please visit the company’s website at www.Playgon.com.

NOTE TO INVESTORS: The latest news and updates relating to PLGNF are available in the company’s newsroom at https://ibn.fm/PLGNF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork

Siyata Mobile (NASDAQ: SYTA, SYTAW), a global provider of innovative of push-to-talk over cellular (“PoC”) devices and cellular signal booster systems, today announced its receipt of new orders for its SD7 Handsets and VK7 Vehicle Kits totaling more than $400,000 in aggregate. “These orders are further increasing our sales in the second quarter of 2023 and set the stage for sequential quarterly revenue growth for this quarter,” said Marc Seelenfreund, founder and CEO of Siyata. “They are another proof point of accelerating sales momentum with our push-to-talk (‘PTT’) enabled cellular solutions, and they demonstrate further market penetration in the health care, education and construction verticals. Demand for our solutions goes beyond our more traditional vertical of first responders. With these orders, our SD7 Handsets and VK7 Vehicle Kits will be deployed to support a western U.S. health care facility, in schools and in school buses from multiple school districts, and in construction companies for job-site communications. Increasingly, government and commercial organizations are replacing land mobile radio (‘LMR’) devices with PTT enabled cellular solutions, and we are positioning Siyata to be the PTT device provider of choice.”

To view the full press release, visit https://ibn.fm/vcdAb

About Siyata Mobile Inc.

Siyata Mobile is a B2B global provider of innovative, next-generation push-to-talk over cellular (“PoC”) devices, cellular booster systems and video monitoring solutions. Its in-vehicle and rugged devices enable first responders and enterprise workers to instantly communicate, over a nationwide cellular network of choice, to increase situational awareness and save lives. Its portfolio of enterprise grade and consumer cellular booster systems enables first responders and enterprise workers to amplify cellular signals in remote areas, inside structural buildings where signals are weak and within vehicles for the maximum cellular signal strength possible. For its video monitoring system, Siyata integrates software that it licenses with off-the-shelf hardware providing customers with an integrated advanced camera system for management and visual monitoring of their fleet vehicles. Siyata’s common shares and previously issued warrants trade on the Nasdaq under the symbols SYTA and SYTAW, respectively. For more information about the company, visit www.SiyataMobile.com and UnidenCellular.com.

NOTE TO INVESTORS: The latest news and updates relating to SYTA are available in the company’s newsroom at https://ibn.fm/SYTA          

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork

Blockchain technology experts, crypto enthusiasts, investors, and business owners are invited to attend the Web3 Berlin Conference to be held in Berlin, Germany, June 10-11, 2023. As the technological world is on the verge of evolution, the much-awaited Web3 Berlin Conference is set to unveil the potential of associated disruptive technologies.

Hosting the prominent gathering of unique ideas and intellectual minds, Web3 Berlin Conference promises to celebrate technological innovation. The conference has a rich history of successful…

Read More>>

To learn more, please visit https://ibn.fm/5mTk0.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
Editor@InvestorWire.com

RYVYL (NASDAQ: RVYL), which leverages the security of the blockchain and USD-pegged stablecoin technology with near-real-time attestation to conduct payment transactions, today announced that its board of directors has approved the merger of coyni Inc., RYVYL’s wholly owned subsidiary, and Logicquest Technology Inc., a shell company majority owned by RYVYL. “Today we are pleased to take another meaningful step forward towards completion of our vision to spin-off of coyni as part of our broad value creation strategy,” said Ben Errez, chairman of RYVYL Inc. “Once complete, we’ll commence our capital raising plans with line of sight on a Nasdaq up listing and special share dividend to unlock significant value for our shareholders.”

To view the full press release, visit https://ibn.fm/4xUeI

About RYVYL Inc.

RYVYL was born from a passion for empowering a new way to conduct business-to-business, consumer-to-business and peer-to-peer payment transactions around the globe. By leveraging unique blockchain security and USD-pegged stablecoin technology with near real-time attestation, RYVYL is reinventing the future of financial transactions using its coyni(R) stablecoin platform as a transactional foundation. Since its founding as GreenBox POS in 2017 in San Diego, RYVYL has developed applications enabling an end-to-end suite of turnkey financial products with enhanced security and data privacy, world-class identity theft protection, and rapid speed to settlement. As a result, the platform can log immense volumes of immutable transactional records at the speed of the internet for first-tier partners, merchants and consumers around the globe. For more information, visit www.RYVYL.com

NOTE TO INVESTORS: The latest news and updates relating to RVYL are available in the company’s newsroom at https://ibn.fm/RVYL

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork

• Digital money is replacing physical cash, and FEXD is developing mobile transaction platforms and services that are helping implement the coming changes in the fintech market
• FEXD plans to acquire and merge with companies that include country-based fintech pioneers with global scalability, fintech service providers, companies with large customer bases, and more
• The company is helping ensure humanity has a path forward from archaic and restrictive cash systems – reducing poverty, improving the lives of the unbanked, providing critical financial options for migrant workers, connecting families and communities, empowering charities and women, and educating underprivileged children

With plans to offer a diverse portfolio of fintech-related products and services for consumers and businesses in the United States, South Asia, East Asia, Africa, Europe, and Latin America, Fintech Ecosystem Development (NASDAQ: FEXD) continues to move forward in the service of underserved and overlooked markets within the global financial ecosystem. The FEXD management team has extensive experience in developing and managing financial service platforms and applications, primarily in the mobile money sector, driving the move to a cashless society.

Digital money is replacing physical cash, with consumers able to buy products and services anywhere in the world and make payments across borders. FEXD is developing mobile transaction platforms and services that are helping implement the coming changes – especially in underserved and overlooked…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to FEXD are available in the company’s newsroom at https://ibn.fm/FEXD

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
Editor@InvestorWire.com

Noble Capital Markets, host of NobleCon19, announced that George W. Bush will be a featured speaker during an hourlong fireside chat at this year’s event. Noble’s 19th annual Emerging Growth Conference will be held Dec. 3–5, 2023, in Boca Raton, Florida. President Bush’s fireside presentation will be moderated by Noble’s director of research, Michael Kupinski.

The 43rd president of the United States and founder of the George W. Bush Presidential Center, Bush served as president of the United States of America from 2001–2009. He worked to expand freedom, opportunity and security at home and abroad, and hallmarks of his administration include reforming America’s education system, restoring robust private-sector economic growth and job creation, protecting the environment, and pursuing a comprehensive strategy to keep America safe after the terrorist attacks on Sept. 11, 2001.

The fireside chat will provide a casual environment in which Bush will discuss his time in the Oval Office and the challenges the nation is facing today. The two-day NobleCon event will provide executive teams from more than 100 companies across North America an opportunity to introduce their companies through formal presentations, Q&A sessions, organized breakouts and one-on-one meetings to institutional investors, licensed brokers and accredited investors.

To view the full press release, visit https://ibn.fm/aHXMx

About Noble Capital Markets Inc.

Noble Capital Markets, Inc. was incorporated in 1984 as a full-service SEC/FINRA registered broker-dealer, dedicated exclusively to serving underfollowed emerging-growth companies through investment banking, wealth management, trading and execution, and equity research activities. Over the past 39 years, Noble has raised billions of dollars for companies and published more than 45,000 equity research reports. For more information about the company, please visit www.NobleCapitalMarkets.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing therapies for patients with cancer and diabetes who have limited treatment options, has released a video featuring a patient from a recent clinical trial. The patient participated in the phase 1 portion of Genprex’s Acclaim-1 study. During the video, the patient shares her experience, which includes extended Progression Free Survival (“PFS”) resulting from taking REQORSA(R), Genprex’s lead drug candidate. The patient is still taking the drug and is also still participating in the phase 1 portion of the Acclaim-1 clinical trial. According to the announcement, Genprex is working with world-class institutions to develop new drugs featuring the company’s pipeline of gene therapy candidates. Specifically, the company’s oncology program utilizes its proprietary nonviral ONCOPREX(R) Nanoparticle Delivery System, which Genprex believes is the first systemic gene therapy delivery platform used for cancer in humans. The company’s lead drug candidate is called REQORSA, an immunogene therapy for both non-small cell lung cancer (“NSCLC”) and small cell lung cancer (“SCLC”). “While on REQORSA treatment, my doctor noted that the lung cancer lesions have not grown and there is no new growth,” said the NSCLC patient in the phase 1 portion of Acclaim-1. “I believe the REQORSA treatment has benefited my life and has increased my time.”

To view the full patient interview, visit https://ibn.fm/Ny9QU

To view the full press release, visit https://ibn.fm/OEQdj

About Genprex Inc. 

Genprex is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Genprex’s technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes, which currently have limited treatment options. Genprex works with world-class institutions and collaborators to develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches. Genprex’s oncology program utilizes its proprietary, nonviral ONCOPREX(R) Nanoparticle Delivery System, which encapsulates the gene-expressing plasmids using lipid nanoparticles. The resultant product is then administered intravenously, where it is then taken up by tumor cells that express tumor suppressor proteins that are deficient in the tumor. The company’s lead product candidate, REQORSA (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for non-small cell lung cancer (“NSCLC”) and small cell lung cancer (“SCLC”). Both NSCLC clinical programs received a fast track designation from the Food and Drug Administration. Genprex’s diabetes gene therapy approach is comprised of a novel infusion process that uses an endoscope and an adeno-associated virus (“AAV”) vector to deliver Pdx1 (“Pdx1”) and MafA (“MafA”) genes to the pancreas. In models of type a diabetes, GPX-002 transforms alpha cells in the pancreas into functional beta-like cells, which can produce insulin but are distinct enough from beta cells to evade the body’s immune system. In a similar approach, GPX-003 for type w diabetes, where autoimmunity is not at play, is believed to rejuvenate and replenish exhausted beta cells. For more information, please visit the company’s website at www.Genprex.com.

NOTE TO INVESTORS: The latest news and updates relating to GNPX are available in the company’s newsroom at http://ibn.fm/GNPX

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork

Silo Pharma (NASDAQ: SILO), a developmental-stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, is now actively participating on the Webull Corporate Communications Service (“CCS”) Platform. Silo Pharma’s portal on the platform provides an additional channel for direct investor communication and audience engagement, even allowing questions and answers. The move also means that Webull’s investor community can access the SILO profile for real-time data and investor communications. “We are excited to share SILO’s new profile on Webull’s Corporate Communications Service Platform and invite investors to take advantage of this convenient and engaging digital communications channel,” said Silo Pharma CEO Eric Weisblum in the press release. “The Webull CCS platform is an additional investor relations tool that magnifies our company’s accessibility and transparency for active retail investors and enables us to share unique content and communicate with them in real time.”

To view the full press release, visit https://ibn.fm/ooPrC

About Silo Pharma Inc.

Silo Pharma is a developmental-stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research for people suffering from indications such as PTSD, Alzheimer’s disease and other rare neurological disorders. Silo’s mission is to identify assets to license and fund the research that the company believes will be transformative to the well-being of patients and the healthcare industry. For more information about the company, visit www.SiloPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to SILO are available in the company’s newsroom at https://ibn.fm/SILO

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork

VCI Global (NASDAQ: VCIG), a multidisciplinary consulting group with key advisory practices in the areas of business and technology, is expanding into the digital asset market with its just-announced subscription for 500 new GlobexUS Holdings Corp (“GlobexUS”) shares. According to the company, the shares will be subscribed at $3,000 per share for a total of $1.5 million. The announcement noted that GlobexUS is the holding company of the 50/50 joint venture technology partner of Upstream Exchange, a MERJ Exchange market. Upstream is the world’s first regulated exchange that lists blockchain-based digital securities to be traded on its retail marketplace; the market allows U.S and global securities issuers to dual list their shares on the platform. In addition to subscribing to the shares, VCI Global has entered into a marketing and referral agreement with Upstream. According to the agreement, VCI Global has exclusive rights to introduce and refer entities that wish to list or dual list on Upstream in the territories of Malaysia, Singapore and Indonesia. “As the global economies pull further away from the pandemic era, we are committed to maintain our growth strategy plan to maintain our position as a leading global advisory firm,” said VCI Global executive chair and CEO Dato’ Victor Hoo in the press release. “The acquisition of the stake [in GlobexUS] is synergistic given our related referral arrangement. Undoubtedly a win-win situation for all parties concerned. This partnership with Upstream will open up a new revenue stream for us, which, we believe, will increase the valuation of VCI Global significantly once it gains traction.”

To view the full press release, visit https://ibn.fm/33DZu

About VCI Global Limited

VCI Global is a multidisciplinary consulting group with key advisory practices in the areas of business and technology. The company provides business and boardroom strategy services, investor relation services and technology consultancy services. Its clients range from small to medium enterprises and government-linked agencies to publicly traded companies across a broad array of industries. VCI Global operates solely in Malaysia, with clients predominantly from Malaysia, but the company also serves clients from China, Singapore and the United States. For more information, visit the company’s website at https://V-Capital.co.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork

Tingo Group Inc. (NASDAQ: TIO), a global fintech and agri-fintech group of companies with operations in Africa, southeast Asia and the Middle East, is providing a 3 billion Naira (approximately USD$6.5 million) loan facility to the All Farmers Association of Nigeria (“AFAN”). The purpose of the loan, which is approximately US$6 million, is for the new cultivation of 3,000 hectares of farming land to be used for rice and wheat production. According to the announcement, the cultivation of the land will produce more than 6,000 metric tons of wheat and 16,000 metric tons of rice every year. The company noted that this is the first of many similar agreements it plans to make with AFAN as part of its strategy to support and increase food-production levels and significantly increase crop supply for Tingo businesses. “We are delighted to extend and strengthen our relationship with AFAN through this agreement,” said Tingo Foods CEO Darren Mercer in the press release.

“By supporting AFAN and its farmers to cultivate more land and improve crop production levels, we are not only helping Nigeria’s agricultural community, we are also generating more business for Tingo Mobile and delivering more produce to Tingo Foods and our Tingo DMCC export business. This is truly a win-win situation, and one that fits exceptionally well with our ESG commitments. Today’s agreement, together with the series of other such deals that we plan to execute on going forward, are yet another means for us to advance our goal of increasing food production levels, while also meaningfully increasing revenues and net earnings across a number of our businesses, which are enhanced by the synergistic attributes of our unique ecosystem. We are also very excited about the business impact of AFAN’s commitment to allocate part of our loan facility to accelerate their onboarding of warehouses as we expect the enlargement of the warehouse network to materially assist us to reduce crop wastage and achieve higher levels of crop utilization and again further increase the supply of produce into Tingo Foods and Tingo DMCC.”

To view the full press release, visit https://ibn.fm/zzVPf

About Tingo Group Inc.

Tingo Group is a global fintech and agri-fintech group of companies with operations in Africa, southeast Asia and the Middle East. Tingo Group’s wholly owned subsidiary, Tingo Mobile, is the leading agri-fintech company operating in Africa, with a comprehensive portfolio of innovative products, including a device-as-a-service smartphone and preloaded platform product. As part of its globalization strategy, Tingo Mobile has recently begun to expand internationally and entered into trade partnerships that are contracted to increase the number of subscribed farmers from 9.3 million in 2022 to more than 32 million, providing the farmers with access to services such as the Nwassa seed-to-sale marketplace platform, insurance, microfinance, and mobile phone and data top-up. Tingo Group’s other Tingo business verticals include TingoPay, a SuperApp in partnership with Visa that offers a wide range of B2C and B2B services including payment services, an e-wallet, foreign exchange and merchant services; Tingo Foods, a food-processing business that processes raw foods into finished products such as rice, pasta and noodles; and Tingo DMCC, a commodity trading platform and agricultural commodities export business based out of the Dubai Multi Commodities Center. In addition to its Tingo business verticals, Tingo Group also holds and operates an insurance brokerage platform business in China, with more than 130 offices located in China’s cities and major towns; and Magpie Securities, a regulated finance services fintech business operating out of Hong Kong and Singapore. For more information, visit the company’s website at www.TingoGroup.com.

NOTE TO INVESTORS: The latest news and updates relating to IWBB are available in the company’s newsroom at https://ibn.fm/TMNA

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork

Amesite (NASDAQ: AMST) will be participating in the live Benzinga All Access event that is scheduled for today. According to the announcement, Amesite CEO Dr. Ann Marie Sastry will present during today’s event; her presentation is scheduled to begin at 11 a.m. ET. Amesite is a leading artificial intelligence software company offering a cloud-based learning platform for business and education markets. Sastry’s discussion will include an overview of the company and will focus on the company’s goal to provide students with next-generation upskilling that is designed to prepare them for a variety of changes, including changes in the economy. The discussion will include other exciting company developments as well.

To view the full presentation, visit https://ibn.fm/9aiMt

To view the full press release, visit https://ibn.fm/Y9foa

About Amesite Inc.

Amesite delivers its scalable, customizable, white-labeled online learning platform to universities, businesses, museums and government agencies, enabling them to deliver outstanding digital learning. Amesite provides a single system that combines eCommerce, instruction, engagement, analytics and administration using best-in-class infrastructure to serve multibillion-dollar online learning markets. For more information about the company, please visit www.Amesite.io.

NOTE TO INVESTORS: The latest news and updates relating to AMST are available in the company’s newsroom at https://ibn.fm/AMST

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork

GolfLync, the company behind the GolfLync app – a social network for matching golf games and players, today announced that it has selected the corporate communications expertise of IBN, a multifaceted financial news and publishing company for private and public entities. As part of the client partner relationship, IBN will generate greater awareness for GolfLync through leveraging its investor based distribution network of 5,000+ key syndication outlets, various newsletters, social media channels, wire services via InvestorWire, blogs and other outreach tools. “The growth of the GolfLync app in recent months has been phenomenal. With over 20,000 downloads and a cumulative five-star rating across 200+ reviews on the Apple App Store, it’s clear that the market has been waiting for a golf-centric networking option,” said Chris Johnson, director of client solutions for IBN. “We’re excited to customize our comprehensive suite of corporate communications solutions for GolfLync Inc. as the company works to build on its momentum and continue bringing likeminded golfers across the country together…”

To view the full press release, visit https://ibn.fm/ROudC

About GolfLync Inc.

GolfLync is creating a new experience for golf lovers, connecting them with likeminded friends and groups with whom they can golf. Built to scale, GolfLync is ready to connect millions of players across the country and has groups forming in cities and at courses across America. Features include streaming feeds with social posts from golf players and groups across America, posting and finding tee times and, of course, chatting about golf! For more information, visit the company’s website at www.GolfLync.com.

NOTE TO INVESTORS: The latest news and updates relating to GolfLync are available in the company’s newsroom at https://ibn.fm/GOLF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork

FMW Media’s business TV show, New to The Street, has announced the signing of a 12-month contract for filming and broadcasting tailored interviews and commercials about Pressure BioSciences (OTCQB: PBIO) (“PBI”). According to the announcement, New to The Street’s TV anchors will interview the management team at PBIO with each show airing on its televised syndicated outlets on Newsmax and Fox Business Network, sponsored program on Bloomberg TV, and website www.NewtoTheStreet.com. “I look forward to appearing on New to The Street, to share our company’s business success stories with viewers,” said Richard T. Schumacher, president and CEO of Pressure BioSciences. “PBIO commercializes its patented technologies to create and deploy products that are uniquely transformative in their markets. We are particularly excited about our UltraShear platform, now poised for explosive growth as a game-changer to the basis of competition across multiple diverse major markets. During each show, the objective will be to inform viewers about the company growth strategies, current/ future products, and expected opportunities.”

To view the full press release, visit https://ibn.fm/eh49G

About Pressure BioSciences Inc.

Pressure BioSciences is a global leader in providing innovative, broadly enabling, high-pressure-based solutions for a range of industries, including biotechnology, pharmaceutical, nutraceutical, cosmeceutical and agrochemical, as well as food and beverage manufacturing. The company’s products utilize both constant and alternating pressure. Pressure BioSciences’ patented Pressure Cycling Technology (“PCT”) utilizes alternating cycles of pressure to control bio-molecular interactions (such as cell lysis and biomolecule extraction) safely and reproducibly. PCT-based products are beginning to be widely used for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil and plant biology, forensics, and counter-bioterrorism applications. The company has recently expanded its market opportunities with the acquisition of the BaroFold(TM) patented technology platform, allowing it to enter the bio-pharma contract services and GMP manufacturing equipment sector. Pressure BioSciences has also developed the scalable and high-efficiency pressure-based UltraShear Technology(TM) (UltraShear(TM) or UST(TM)) platform, which allows for the creation of stable nanoemulsions of otherwise immiscible fluids. It also allows for the preparation of higher quality, homogenized, extended shelf-life or room temperature-stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies. The company’s commitment to innovation and cutting-edge technology has established PBIO as a leader in the high-pressure industry, providing unique and effective solutions to its customers. For more information about the company, visit www.PressureBioSciences.com.

NOTE TO INVESTORS: The latest news and updates relating to PBIO are available in the company’s newsroom at http://ibn.fm/PBIO

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork

PlantX Life (CSE: VEGA) (Frankfurt: WNT1) (OTC: PLTXF), the digital face of the plant-based community operating a one-stop shop for plant-based products, is releasing its unaudited monthly financial metrics for April 2023, with gross profit improving significantly across all key growth areas of the business. According to the announcement, the company reported gross revenues for the month of $897,000, an 11% increase from the previous month. The company attributed the increase to strong growth in its PlantX Midwest, PlantX UK and Vegan Essentials sectors and noted that gross margins expanded 323 basis points, indicating progress in achieving profitability. The company also reported that its Locavore Bar & Grill concept and Portfolio Coffee beverage business continue to generate double-digit growth; PLTXF’s Little West cold-pressed juice business saw 6% growth as well. “Our geographic expansion, building on our growing reputation in California, Canada and online, is driving top- and bottom-line growth,” said PlantX Life CEO Lorne Rapkin in the press release. “We have established a robust platform, representing the most valuable plant-based assets in the ecosystem, and this portfolio is leading to greater brand awareness, increasing cross-selling and cross-promotion opportunities and facilitating geographic expansion. We continue to drive notable growth in the Chicagoland area, as well as the UK, and we recently launched our Israeli ecommerce site, furthering our global expansion. Importantly, our geographic expansion and the concepts and products where we are focusing our efforts all generated improved profit margins, demonstrating significant progress in our path to profitability. We are nearing a key inflection point, where additional growth should drive disproportionate improvement in our profitability as we more effectively leverage our established platform and our competitive position in the marketplace. The addition of leading brands to our ecommerce properties is another example of this, as we add profitable revenue with little or no fixed costs, accelerating our profitability initiatives.”

To view the full press release, visit https://ibn.fm/VgwIr

About PlantX Life Inc.

PlantX is committed to being the digital face of the plant-based community as well as the one-stop shop for plant-based products. With its fast-growing category verticals, the company offers customers across North America more than 5,000 plant-based products. PlantX also has other brands in the PlantX portfolio, including a juice brand, a coffee company, a plant shop and brick-and-mortar grocery stores. PlantX uses its digital platform to build a community of like-minded consumers and, most importantly, to provide education. PlantX’s digital presence eliminates entry barriers for anyone interested in living a plant-based lifestyle and thriving in a longer, healthier and happier life. For more information about this company, please visit www.PlantX.com and www.PlantX.ca.

NOTE TO INVESTORS: The latest news and updates relating to PLTXF are available in the company’s newsroom at https://ibn.fm/PLTXF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork

DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, will be attending and participating in the Stifel 2023 Virtual Cross Sector Insight Conference. The two-day event is scheduled to be held in Boston on June 6–7, 2023. According to the announcement, DarioHealth president Rick Anderson will be presenting at the conference; his presentation will feature an overview of the company and is slated to begin at 4:45 p.m. EST on June 6. In addition to the presentation, Anderson will also be participating in one-on-one meetings with conference attendees.

To view the full presentation, visit https://ibn.fm/K9M41

To view the full press release, visit https://ibn.fm/WWkB5

About DarioHealth Corp.

DarioHealth Corp. is a leading digital health company revolutionizing how people with chronic conditions manage their health through a user-centric, multichronic condition digital therapeutics platform. Dario’s platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain and behavioral health. The company’s user-centric platform offers people continuous and customized care for health, disrupting the traditional episodic approach to healthcare. This approach empowers people to holistically adapt their lifestyles for sustainable behavior change, driving exceptional user satisfaction, retention and results, and making the right thing to do the easy thing to do. Dario provides its highly user-rated solutions globally to health plans and other payors, self-insured employers and providers of care as well as directly to consumers. For more information about the company, please visit www.DarioHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to DRIO are available in the company’s newsroom at http://ibn.fm/DRIO

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork

Vistagen Therapeutics (NASDAQ: VTGN), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other central nervous system (“CNS”) disorders, has reported the results of its phase 3 open-label study of fasedienol (“PH94B”) nasal spray for the treatment of adults with social anxiety disorder (“SAD”). The company presented the results during at the 2023 annual meeting for the American Society for Clinical Psychopharmacology (“ASCP”), which was held earlier this week. The phase 3 study evaluated the long-term safety and tolerability of multiple, patient-tailored, as-needed administrations of fasedienol in adults dealing with SAD, specifically when they were experiencing social and performance stressors. According to the announcement, data gathered from nearly 500 patients in real-world settings indicate that patient-tailored, as-needed administrations of fasedienol over time were safe and well tolerated. During the presentation, the company reported that positive exploratory fasedienol efficacy data measured by the Liebowitz Social Anxiety Scale (“LSAS”) demonstrated clinically meaningful reductions in fear, anxiety and avoidance of anxiety-provoking social and performance situations in daily life; the results built on LSAS data gathered from a previous real-world, placebo-controlled phase 2 study. “These data advance the body of evidence supporting fasedienol’s safety profile and potential to achieve overall reduction in anxiety for adults suffering with social anxiety disorder, and we were excited to present these important findings to the ASCP community,” said Vistagen Therapeutics CEO Shawn Singh in the press release. “There are significant gaps in care for mental health patients, and many are seeking fast-acting medications with a favorable safety profile. When used as-needed and over time in their daily lives, as in this open-label study and a prior placebo-controlled phase 2 study, we believe fasedienol, with its exceptional safety profile, has the potential to help change the treatment landscape for social anxiety disorder.”

To view the full press release, visit https://ibn.fm/sc0Yc

About Vistagen Therapeutics Inc.

Vistagen Therapeutics is a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other CNS disorders. The company is advancing therapeutics with the potential to be faster acting, and with fewer side effects and safety concerns than those that are currently available for treatment of anxiety, depression and CNS disorders. Vistagen’s pipeline includes six clinical-stage product candidates, including five investigational agents belonging to a new class of drugs known as pherines, in addition to AV-101, an oral antagonist of the glycine site of the N-methyl-D-aspartate receptor (“NMDAR”). Pherines, which are administered as nasal sprays, are designed with an innovative rapid-onset mechanism of action that activates chemosensory neurons in the nasal passages and can selectively and beneficially impact key neural circuits in the brain without requiring systemic uptake or direct activity on CNS neurons. Vistagen’s AV-101 inhibits activity of the ion channel of the NMDAR but does not block it. Vistagen is passionate about transforming mental health care and redefining what is possible in the treatment of anxiety, depression and several other CNS disorders. For more information about the company, please visit www.Vistagen.com.

NOTE TO INVESTORS: The latest news and updates relating to VTGN are available in the company’s newsroom at https://ibn.fm/VTGN  

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork

Siyata Mobile (NASDAQ: SYTA) (TSX.V: SIM), a global provider of innovative Push-to-Talk (“PTT”) over Cellular (“PoC”) and cellular signal booster solutions, has received a $1.2 million order for its UV350 In-Vehicle Devices along with Siyata Real Time View, the company’s new video monitoring service. The service features advanced camera-management and visual-monitoring capabilities that provide Siyata customers with real-time viewing and notifications solutions for their fleet vehicles. According to the announcement, Siyata anticipates beginning to ship the product in Q2 of this year as well as seeing recurring revenue from the product. “This order is from a repeat customer that is already experiencing the benefits of our rugged handsets and UV350 In-Vehicle devices,” said Siyata CEO Marc Seelenfreund in the press release. “As such, they are adding more UV350 In-Vehicle devices to their fleet of ambulances in addition to our newest product, Siyata Real Time View, which provides in-fleet video monitoring. By equipping their fleet with our technology, this EMS organization will enable better collaboration and improve command and control of critical communications across its operation. Importantly, this creates a recurring revenue stream for Siyata from a license fee for using the video software that further increases the lifetime value of this customer. . . . Siyata Real Time View provides better control for fleet managers and better safety for commercial vehicle drivers. Beyond emergency services, Real Time View is ideal for municipalities, construction, taxis or any enterprise customer that wants to improve control over its fleet. Video produced by Real Time View is high resolution and can be accessed from a management portal in real time or retrieved later via cloud storage. It is a perfect addition to our product portfolio as it addresses the needs of our EMS and commercial vehicle enterprise customers using our PTT portfolio.”

To view the full press release, visit https://ibn.fm/2bDvc

About Siyata Mobile Inc.

Siyata Mobile is a B2B global vendor of next-generation, Push-to-Talk over cellular devices, cellular booster systems and video-monitoring systems. Its portfolio of in-vehicle and rugged devices enable first responders and enterprise workers to instantly communicate, over a nationwide cellular network of choice, to increase situational awareness and save lives. The company’s portfolio of enterprise-grade and consumer cellular booster systems enables first responders and enterprise workers to amplify cellular signal in remote areas, inside structural buildings where signals are weak and within vehicles for the maximum cellular signal strength possible. For its video monitoring system, Siyata integrates software licensed with off-the-shelf hardware providing customers with an integrated advanced camera system for management and visual monitoring of their fleet vehicles. For more information about the company, visit www.SiyataMobile.com or www.UnidenCellular.com.

NOTE TO INVESTORS: The latest news and updates relating to SYTA are available in the company’s newsroom at http://ibn.fm/SYTA

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork

Tingo Group Inc. (NASDAQ: TIO) today announced that it has become aware of credible evidence that a New York-based financial institution has been soliciting investors with an offer of the company’s securities with the pretense of a fund raise, which was in direct contravention of the company’s explicit wishes. The company is not planning any placement, offering or issuance of its equity securities and has expressly instructed the NY financial institution not to conduct any such solicitation. Tingo Group has also demanded that the NY financial institution notify all the parties solicited to date and inform them that the company is not planning any form of equity fundraising. “We believe that the false marketing by this financial institution has had a materially negative impact on our share price, including on Tuesday, May 30, 2022, when we issued the announcement of our significant export transactions and export deal pipeline,” said Darren Mercer, chief executive officer of Tingo. “Our lawyers have been instructed to investigate the actions of the financial institution and their associates and also provide an assessment of the damages caused to both the company and to its shareholders. The two law firms have extensive experience, and have achieved much success, representing companies in bringing claims against financial institutions for, among other things, breach of various rules and regulations, breach of contract, breach of fiduciary duty, perpetration of stock manipulation, and other securities violations.”

To view the full press release, visit https://ibn.fm/13cjb

About Tingo Group Inc.

Tingo is a global fintech and agri-fintech group of companies with operations in Africa, Southeast Asia and the Middle East. The company’s wholly owned subsidiary, Tingo Mobile, is the leading agri-fintech company operating in Africa, with a comprehensive portfolio of innovative products, including a ‘device as a service’ smartphone and pre-loaded platform product. As part of its globalization strategy, Tingo Mobile has recently begun to expand internationally and entered into trade partnerships that are contracted to increase the number of subscribed farmers from 9.3 million in 2022 to more than 32 million, providing them with access to services including, among others, the Nwassa ‘seed-to-sale’ marketplace platform, insurance, micro-finance, and mobile phone and data top-up. The company’s other Tingo business verticals include: TingoPay, a SuperApp in partnership with Visa that offers a wide range of B2C and B2B services including payment services, an e-wallet, foreign exchange and merchant services; Tingo Foods, a food processing business that processes raw foods into finished products such as rice, pasta and noodles; and Tingo DMCC, a commodity trading platform and agricultural commodities export business based out of the Dubai Multi Commodities Center. In addition to its Tingo business verticals, the company also holds and operates an insurance brokerage platform business in China, with 130+ offices located in China’s cities and major towns; and Magpie Securities, a regulated finance services fintech business operating out of Hong Kong and Singapore. For more information about the company, visit www.TingoGroup.com.

NOTE TO INVESTORS: The latest news and updates relating to TIO are available in the company’s newsroom at https://ibn.fm/TIO

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork

Starco Brands (OTCQB: STCB), a company with an unwavering mission to invent and acquire consumer products and brands with behavior-changing technologies that spark excitement in the everyday, was featured in the latest episode of Bell2Bell Podcast. The podcast is part of IBN’s sustained effort to provide specialized content distribution via widespread syndication channels. Ross Sklar, CEO of Starco Brands, joined the program to discuss the company’s business model, operating markets and its approach to building an innovative portfolio. “One of our first products that we launched was Winona(R) Popcorn Spray … We developed it because we analyzed the proverbial popcorn bay at retail. In that bay, there’s just not a lot of technology,” Sklar said. “We’ve got a lot of capability in cooking sprays, and we thought about how to dig in with the consumer and provide a sensory experience that maybe they haven’t had. The thesis of the product was that when someone has a bowl of popcorn, they take their seasoning and shake, shake, shake, then it’s all at the bottom of the bowl. Now, you can spray and have tremendous coverage rates with this beautiful smell. You can really almost mimic theater-style popcorn at home. That was a really interesting sensory proposal and disruption in the category… When we went to the buyers and said, ‘Hey, we have innovation,’ they were thrilled.”

To view the full press release, visit https://ibn.fm/VWUfY

About Starco Brands, Inc.

Starco Brands invents consumer products with behavior-changing technologies that spark excitement in the everyday. Today, its disruptive brands include: Whipshots(R), the world’s only vodka-infused whipped cream; Art of Sport, the body care brand designed for athletes and co-founded by Kobe Bryant; Winona(R) Popcorn Spray, the first indulgent theater-popcorn spray powered by air; Skylar, the only fragrance that is both hypoallergenic and safe for sensitive skin; and Soylent, the complete non-dairy nutrition brand. A modern-day invention factory to its core, Starco Brands identifies whitespaces across consumer product categories. It draws upon a portfolio of innovative formulas spanning eight product categories with limitless innovation potential. Starco Brands publicly trades on the OTCQB stock exchange so that retail investors can invest in STCB alongside accredited individuals and institutions. Visit www.StarcoBrands.com for more information.

NOTE TO INVESTORS: The latest news and updates relating to STCB are available in the company’s newsroom at https://ibn.fm/STCB

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork

Pharma, biotech, medical device, healthcare, and regulatory professionals are gathering for the 4th Aligning Drug Safety Functions & REMS Summit, taking place on August 29-30, 2023, at The Inn at Penn in Philadelphia, PA.

Set to take place in the beautiful city of Philadelphia, the conference will delve into the latest insights and address the most critical challenges surrounding drug safety and…

Read More>>

To learn more, please visit https://ibn.fm/otdWA.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
Editor@InvestorWire.com

Cybin (NYSE American: CYBN) (NEO: CYBN) is a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment options. The company today announced that its Chief Executive Officer Doug Drysdale will present at the Jefferies Healthcare Conference taking place in New York City from June 7-9, 2023. Drysdale’s presentation will be webcast live at 8:00 a.m. ET on Friday, June 9. Interested parties should visit https://ibn.fm/e6mSx to register and access the webcast. The archived webcast will also be available on the company’s investor relations website.

To view the full press release, visit https://ibn.fm/4gxT1

About Cybin Inc.

Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. Cybin’s goal of revolutionizing mental health care is supported by a network of world-class partners and internationally recognized scientists aimed at progressing proprietary drug discovery platforms, innovative drug delivery systems, and novel formulation approaches and treatment regimens. The company is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. Headquartered in Canada and founded in 2019, Cybin is operational in Canada, the United States, the United Kingdom, the Netherlands and Ireland. For more information, visit the company’s website at www.Cybin.com.

NOTE TO INVESTORS: The latest news and updates relating to CYBN are available in the company’s newsroom at https://ibn.fm/CYBN

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork

Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX), an innovator in automotive vision systems, has released its financial results for the first quarter of 2023. According to the report, the company ended Q1 2023 with $21.7 million in cash, cash equivalents, restricted cash and short-term deposits and saw a U.S. Generally Accepted Accounting Principles (“GAAP”) net loss of $4.6 million for the same period along with a non-GAAP net loss of $4.2 million. The company also reported key corporate highlights. “Foresight’s industry-leading technology continued to gain momentum during the first quarter of 2023,” said Foresight CEO Haim Siboni in the press release. “We are particularly pleased by our achievements in the Asia-Pacific (‘APAC’) region, as we began an additional important joint proof-of-concept (‘POC’) project with a leading Japanese global vehicle manufacturer. Foresight Changzhou Automotive Ltd., our fully owned subsidiary in Jiangsu Province, China, received special recognition from the China Israel Changzhou Innovation Park, and Eye-Net Mobile Ltd., our wholly owned subsidiary, received its first order for the Eye-Zone(TM) V2X automotive system from a leading Japanese automotive manufacturer. The first quarter also saw a key breakthrough for Rail Vision Ltd., our affiliate, which received an order from Israel Railways for 10 Main Line Systems. We believe that these achievements for Foresight, Eye-Net and Rail Vision demonstrate the exceptional performance of our technology, as our POC projects are in the process of converting into orders from leading organizations in the automotive, defense and transportation industries. As we continue to prove our ability to create tailored, high-performance solutions for a diverse customer base, we expect to see increased demand.”

To view the full press release, visit https://ibn.fm/PJPxp

About Foresight Autonomous Holdings Ltd.

Foresight Autonomous Holdings is a technology company developing smart multispectral vision software solutions and cellular-based applications. Through the company’s wholly owned subsidiaries — Foresight Automotive Ltd., Foresight Changzhou Automotive Ltd. and Eye-Net Mobile Ltd. — Foresight develops both “in-line-of-sight” vision systems and “beyond-line-of-sight” accident-prevention solutions. Foresight’s vision solutions include modules of automatic calibration and dense three-dimensional (“3D”) point cloud that can be applied to different markets such as automotive, defense, autonomous vehicles and heavy industrial equipment. Eye-Net Mobile’s cellular-based solution suite provides real-time, precollision alerts to enhance road safety and situational awareness for all road users in the urban mobility environment by incorporating cutting-edge AI technology and advanced analytics. For more information, visit the company’s website at www.ForesightAuto.com.

NOTE TO INVESTORS: The latest news and updates relating to FRSX are available in the company’s newsroom at http://ibn.fm/FRSX

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork

• Starco Brands launches Lime Whipshots(TM) flavor in collaboration with Cardi B., kickstarts “Whip It, Beaches” campaign with teaser post earning nearly 2 million likes in one day
• Whipshots Lime is available now in-store and online on June 14
• “Whip It, Beaches” features a 30-second video and series of images showcasing the product’s use in a variety of summer cocktails
• Whipshots is infused with 10% premium vodka, other flavors include vanilla, caramel, and mocha
• Over 2 million cans of Whipshots have been sold since 2021 launch
• Other Starco Brands offerings include the Art of Sport athletic body care line co-founded by Kobe Bryant, Skylar hypoallergenic perfumes, Winona popcorn spray, Soylent plant-based food product line

Starco Brands’ (OTCQB: STCB) “Summer of Whipshots(TM)” kicked into high gear with the launch of Lime Whipshots – the company’s latest addition to its vodka-infused whipped cream product line featuring global icon Cardi B (https://ibn.fm/BOJRg). Currently available in retail stores, Lime Whipshots is scheduled to drop online on June 14 as part of the brand’s “Whip It, Beaches” campaign.

“Whip It, Beaches” features Cardi B. in a 30-second video and series of images showcasing the product’s use in various summer drinks, including mojitos, margaritas, and daiquiris. The campaign is already generating significant buzz among Cardi’s 164 million followers, with nearly 2 million likes on the…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to STCB are available in the company’s newsroom at https://ibn.fm/STCB

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
Editor@InvestorWire.com

Playgon Games (TSX.V: DEAL) (OTC: PLGNF) (FSE: 7CR), a proprietary SaaS technology company delivering mobile live dealer technology to online gaming operators globally, is reporting on its financial and operational results for Q1 2023, the period ended March 31, 2023. Notable numbers from the report include total revenues of C$288,009) from its Live Dealer platform, which is a 104% increase year over year and a net loss of 2% for the same period. According to the report, Playgon saw rising growth in player activity, likely based on new onboards and organic growth within its existing core customer base, which is a strong indicator for future revenue growth; the company noted that it plans to continue its investment in the Live Dealer platform. Operational highlights from the report pointed to several key performance indicators, including wagering turnover for the quarter totaling C$336 million compared to C$275.6 million the previous quarter and average daily wagering turnover for the same period increasing 24%, totaling C$3.71 million. “We kicked off our year with positive momentum in several KPI’s we track, and this is continuing into our second quarter,” said Playgon Games CEO Darcy Krogh in the press release. “The continued and accelerating growth in top line revenue adds to our confidence that our growth strategy is working and gaining meaningful traction in 2023.”

To view the full press release, visit https://ibn.fm/tEO8L

About Playgon Games Inc.

Playgon is a SaaS technology company focused on developing and licensing digital content for the growing iGaming market. The company provides a multitenant gateway that allows online operators the ability to offer their customers innovative iGaming software solutions. Playgon’s current software platform includes Live Dealer Casino, E-Table games and Daily Fantasy Sports, which, through a seamless integration at the operator level, allows customer access without having to share or compromise any sensitive customer data. As a true business-to-business digital content provider, Playgon products are ideal turnkey solutions for online casinos, sportsbook operators, land-based operators, media groups and big database companies. For more information about the company, please visit www.Playgon.com. 

NOTE TO INVESTORS: The latest news and updates relating to PLGNF are available in the company’s newsroom at https://ibn.fm/PLGNF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork

Sharing Services Global Corporation (OTCQB: SHRG) today announced the launch of SigmaPay, a full-service payment processing company that is an integral part of the company’s new Shared Services Platform. According to the announcement, SigmaPay is designed to deliver a comprehensive enterprise payment processing solution to companies in the direct-selling industry. SigmaPay leverages streamlined technology and offers cost-effective, integrated payment processing services ranging from point-of-sale, virtual and mobile transactions to 3D secure fraud protection – all with competitive transactional rates. “At Sharing Services, our goal is to provide premier enterprise-level solutions for every aspect of our customers’ needs,” said Sharing Services CEO John “JT” Thatch. “SigmaPay is one of the key components of our Shared Services Platform, which also includes consulting and financial services for insurance, logistics and even mobile apps. Our Shared Services Platform incorporates the absolute highest-caliber solutions for the companies we partner with.”

To view the full press release, visit https://ibn.fm/oVudA

About Sharing Services Global Corporation

Sharing Services is a publicly traded, diversified company dedicated to maximizing shareholder value through the acquisition and development of innovative companies, products and technologies. The Sharing Services combined platform leverages the capabilities and expertise of various companies that market and sell products direct to the consumer. Additional information is contained in the company’s 10-Q and 10-K filings with the Securities and Exchange Commission. For more information, visit www.SHRGInc.com.

NOTE TO INVESTORS: The latest news and updates relating to SHRG are available in the company’s newsroom at http://ibn.fm/SHRG

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork

Amesite (NASDAQ: AMST) and the National Association for Equal Opportunity in Higher Education (“NAFEO”) today announced successful completed delivery of the first pilot program through their alliance. According to the update, Amesite provided the program to Benedict College, a member of the alliance. The cross-campus pilot, through the course Introduction to the World of Digital Technology, offered upskilling in technology, including internet protocols, data privacy and security and cloud computing. “Working with the team at Benedict has been fantastic, and we’re excited to take what we’ve learned together and scale it, to advance learners across their campus and also to learners in their community,” said Dr. Ann Marie Sastry, Amesite’s CEO.

To view the full press release, visit https://ibn.fm/QSWmQ

About Amesite Inc.

Amesite delivers its scalable, customizable, white-labeled online learning platform to universities, businesses, museums and government agencies, enabling them to deliver outstanding digital learning. Amesite provides a single system that combines eCommerce, instruction, engagement, analytics, and administration using best-in-class infrastructure to serve multibillion-dollar online learning markets. For more information, visit https://amesite.com.

NOTE TO INVESTORS: The latest news and updates relating to AMST are available in the company’s newsroom at https://ibn.fm/AMST

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork

Siyata Mobile (NASDAQ: SYTA, SYTAW), a global provider of innovative of push-to-talk over cellular (“PoC”) and cellular signal booster solutions, today announced that it will be presenting at the LD Micro Invitational XIII. The event is slated to take place at the Luxe Sunset Boulevard Hotel, Los Angeles, California on June 6-8, 2023, and feature 150+ companies, presenting in half-hour increments, as well as private one-on-one meetings. Siyata’s presentation is scheduled to begin at 3:30 p.m. PT on Tuesday, June 6. Interested parties should visit https://ibn.fm/cUL97 to register for the conference and watch the presentation virtually.

To view the full press release, visit https://ibn.fm/ISbVt

About Siyata Mobile Inc.

Siyata Mobile is a B2B global provider of innovative, next-generation push-to-talk over cellular (“PoC”) technology solutions that include its devices and cellular booster systems. Its in-vehicle and rugged device solutions enable first responders and enterprise workers to instantly communicate, over a nationwide cellular network of choice, to increase situational awareness and save lives. Its portfolio of enterprise grade and consumer cellular booster systems enables first responders and enterprise workers to amplify cellular signals in remote areas, inside structural buildings where signals are weak and within vehicles for the maximum cellular signal strength possible. Siyata’s common shares and previously issued warrants trade on the Nasdaq under the symbols SYTA and SYTAW, respectively. For more information about the company, visit www.SiyataMobile.com and UnidenCellular.com.

NOTE TO INVESTORS: The latest news and updates relating to SYTA are available in the company’s newsroom at https://ibn.fm/SYTA          

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork

Red White & Bloom (CSE: RWB) (OTCQX: RWBYF), a multistate cannabis operator and house of premium brands, announced that it has filed required reports for its first quarter 2023, the period ended March 31, 2023. Highlights of the report indicate the company reached $27 million revenue during the quarter and shipped 1 million units of its Platinum Vape during March, making March the first million-unit month for the company. In addition, revenue totaled $27 million, gross profit reached $9.4 million before fair-value adjustments and operating expenses came in at $10.9 million. Corporate highlights included the successful launch of PV’s new infused pre-roll SKU as well as the launch of PV product offerings in the adult-use Arizona market, including more than 12 flavor profiles of its Premium 510 Vapes and Disposable Vape products; the successful activation of the company’s fourth medical-use retail store in Florida, with plans for five more locations in the state; the appointment of Edoardo Mattei as the company’s new CFO; and approvals from Florida’s Office of Medical Marijuana Use for the rebranding of the company’s seed-to-sale, medical-use operations and cannabis product offerings in Florida as House of Platinum. In addition, the company entered into a debenture amending agreement with one lender that initially provides for an amendment to an existing $5,850,000 note for a change in principal with all other terms and conditions remaining the same; the company also entered into a secured debenture agreement with another lender to document Canadian dollar advances, maturing on Sept. 12, 2024.

To view the full press release, visit https://ibn.fm/IZZ8K

About Red White & Bloom Brands Inc.

Red White & Bloom is a multistate cannabis operator and house of premium brands in the U.S. legal cannabis sector. RWB is predominantly focusing its investments on the major U.S. markets, including Arizona, California, Florida, Massachusetts, Missouri and Michigan. For more information about the company, please visit www.RedWhiteBloom.com. 

NOTE TO INVESTORS: The latest news and updates relating to RWBYF are available in the company’s newsroom at https://ibn.fm/RWBYF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork

Cybin (NEO: CYBN) (NYSE American: CYBN), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment options, has inked a common share purchase agreement with an institutional investor: Lincoln Park Capital Fund, LLC (“LPC”). According to the announcement, the agreement strengthens Cybin’s position to deliver on clinical milestones. The agreement notes that Cybin has the right to sell, and LPC is obligated to purchase, up to $30 million common shares over a 36-month period; the shares will be sold based on market price at the time of each sale. Cybin will control the timing and amount of all sales, and there are no warrants, derivatives or other share classes included in the agreement. The company can also terminate the agreement at any time at no cost or penalty. “This committed equity facility by LPC provides us with access to capital on an as-needed basis and is expected to allow Cybin to best utilize market conditions to raise capital in support of our drug development programs,” said Cybin CEO Doug Drysdale in the press release. “The ability to further strengthen our cash position through sales of common shares to LPC under this facility provides additional runway for our success moving forward.”

To view the full press release, visit https://ibn.fm/pXH7P

About Cybin Inc.

Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. Cybin’s goal of revolutionizing mental healthcare is supported by a network of world-class partners and internationally recognized scientists aimed at progressing proprietary drug-discovery platforms, innovative drug-delivery systems, and novel formulation approaches and treatment regimens. The company is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder, and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder; the company also has a research pipeline of investigational psychedelic-based compounds. For more information, visit the company’s website at www.Cybin.com.

NOTE TO INVESTORS: The latest news and updates relating to CYBN are available in the company’s newsroom at https://ibn.fm/CYBN

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork

Vistagen Therapeutics (NASDAQ: VTGN), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other central nervous system (“CNS”) disorders, announced that it will be sharing the results of its phase 3 open-label study of fasedienol (“PH94B”) nasal spray for the treatment of adults with social anxiety disorder (“SAD”). According to the announcement, the results will be reported in a poster presentation at the American Society for Clinical Psychopharmacology (“ASCP”) 2023 annual meeting, which runs from May 30–June 2, 2023. The poster session is slated to begin today at 11:15 a.m. ET. The company reported that its proprietary nasal spray, fasedienol (PH94B), is “a first-in-class, rapid-onset investigational pherine nasal spray with a novel proposed mechanism of action that regulates the olfactory-amygdala neural circuits of fear and anxiety and attenuates the tone of the sympathetic autonomic nervous system, without systemic distribution, potentiation of GABA-A receptors or direct activity on neurons in the brain.” The product is designed for intranasal use in low microgram doses, which is a fundamentally different approach than currently approved anti-anxiety medications, including all antidepressants and benzodiazepines.

To view the full press release, visit https://ibn.fm/Wjujh   

About Vistagen Therapeutics Inc.

Vistagen is a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other CNS disorders. The company is advancing therapeutics with the potential to be faster acting, and with fewer side effects and safety concerns than those that are currently available for treatment of anxiety, depression and CNS disorders. Vistagen’s pipeline includes six clinical-stage product candidates, including five investigational agents belonging to a new class of drugs known as pherines, in addition to AV-101, an oral antagonist of the glycine site of the N-methyl-D-aspartate receptor (“NMDAR”). Pherines, which are administered as nasal sprays, are designed with an innovative rapid-onset mechanism of action that activates chemosensory neurons in the nasal passages and can selectively and beneficially impact key neural circuits in the brain without requiring systemic uptake or direct activity on CNS neurons. Vistagen’s AV-101 inhibits activity of the ion channel of the NMDAR but does not block it. Vistagen is passionate about transforming mental health care and redefining what is possible in the treatment of anxiety, depression and several other CNS disorders. For more information about the company, please visit www.VistaGen.com.

NOTE TO INVESTORS: The latest news and updates relating to VTGN are available in the company’s newsroom at https://ibn.fm/VTGN

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork

Ideanomics (NASDAQ: IDEX), a global company focused on accelerating the commercial adoption of electric vehicles, and its subsidiary, Energica, is working to identify new solutions for electric mobility. As part of those efforts, Energica Inside, Energica’s business unit dedicated to providing innovative solutions for e-mobility, has signed an agreement to develop cutting-edge projects with Plenitude (“Eni”) subsidiary, Be Charge. Be Charge specializes in the dissemination of infrastructure and charging services for electric mobility. According to the announcement, the first objective of the partnership is to apply electric mobility to the nautical sector through a joint innovative project for the installation of charging stations in Italian ports, resulting in providing customers with new displacement options in water. The announcement noted that the synergy between the two companies has already resulted in the development of a new maritime vehicle, a prototype of an electric jet ski, which features technology by Energica Inside. “This agreement represents an important chapter for us to expand our activities, and it is also an incredible opportunity to boost the electrification process in new industries,” said Energica Motor Company CEO Livia Cevolini in the press release. “This is a result that follows on the Energica brand vision towards the expanding of the Italian Electric Valley.”

To view the full press release, visit https://ibn.fm/wiXeL

About Ideanomics Inc.

Ideanomics is a global group with a simple mission: to accelerate the commercial adoption of electric vehicles. By bringing together vehicles and charging technology with design, implementation and financial services, the company provides solutions needed for the commercial world to commit to an EV future. For more information about the company, please visit www.Ideanomics.com.

NOTE TO INVESTORS: The latest news and updates relating to IDEX are available in the company’s newsroom at https://ibn.fm/IDEX

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork

Silo Pharma (NASDAQ: SILO), a developmental-stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, is commencing phase 2 of a study designed to investigate its proprietary SPU-21, a novel joint homing peptides targeting rheumatoid arthritis (“RA”). The company has entered into a research agreement that will evaluate the peptide’s method, optimization and binding affinity in human tissue surrounding joints and tendons. Silo Pharma is working with the University of Maryland, Baltimore to advance the development of SPU-21 liposomal joint homing peptides. “The initial three-month pilot study of SPU-21 assessed the peptide in healthy human and RA synovial tissue,” said Silo Pharma CEO Eric Weisblum in the press release. “The next step is to further investigate cyclic peptides in human tissue assays for optimization and binding affinity.”

To view the full press release, visit https://ibn.fm/0KWSD

About Silo Pharma Inc.

Silo Pharma is a developmental-stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research for people suffering from indications such as PTSD, Alzheimer’s disease and other rare neurological disorders. Silo’s mission is to identify assets to license and fund the research that the company believes will be transformative to the well-being of patients and the healthcare industry. For more information about the company, visit www.SiloPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to SILO are available in the company’s newsroom at https://ibn.fm/SILO

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork